VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Clinical trial NCT07254481 · RECRUITING
Trial details
- NCT number
- NCT07254481
- Sponsor
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-05
- Primary completion
- 2026-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.